Cytokine-Targeted Treatment in Alopecia Areata - New Possibilities?

    May 2023 in “ Prospects in Pharmaceutical Sciences ”
    Michał Stępień, Stanisław Anczyk
    Studysummary This study reviews current treatments for alopecia areata, highlighting that despite various options like corticosteroids and immunosuppressives, their limited efficacy and potential side effects are challenges, while targeting specific cytokines has shown promise except with TNF inhibitors, which may worsen the condition.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on prospects.wum.edu.pl →
    Discuss this study in the Community →

    Research cited in this study 29

    1. Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan Dermatology and therapy · 2021
    2. Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata Experimental dermatology · 2020
    3. New and Emerging Therapies for Alopecia Areata Drugs · 2020
    4. IL-12/IL-23 Neutralization Is Ineffective for Alopecia Areata in Mice and Humans ˆThe ‰journal of allergy and clinical immunology/Journal of allergy and clinical immunology/˜The œjournal of allergy and clinical immunology · 2019
    5. Early Onset of Alopecia Areata After Dupilumab Introduction in a Patient With Atopic Dermatitis European Journal of Dermatology · 2019
    6. New Onset Alopecia Areata During Secukinumab Therapy Dermatologic Therapy · 2019
    7. Efficacy of the Phosphodiesterase-4 Inhibitor, Apremilast, in a Patient with Severe Alopecia Areata European Journal of Dermatology · 2019
    8. Dupilumab And Alopecia: A Janus Effect Dermatologic Therapy · 2019
    9. Apremilast Is Efficacious in Refractory Alopecia Areata Journal of dermatological treatment · 2019
    10. Alopecia Diffusa While Using Interleukin-17 Inhibitors Against Psoriasis Vulgaris Case Reports in Dermatology · 2019
    11. Dupilumab Treatment for Atopic Dermatitis Leading to Unexpected Treatment for Alopecia Universalis JAAD case reports · 2019
    12. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report Acta Dermato Venereologica · 2019
    13. Alopecia Areata After Omalizumab Treatment for Chronic Spontaneous Urticaria Acta Dermato Venereologica · 2019
    14. JAK Inhibitors and Alopecia Areata Lancet · 2019
    15. Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab Journal of Investigational Allergology and Clinical Immunology · 2018
    16. Drug-Induced Alopecia After Dupilumab Therapy JAAD case reports · 2018
    17. A Randomized Placebo-Controlled Single-Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects with Moderate-to-Severe Alopecia Areata Archives of dermatological research · 2018
    18. Response to Ustekinumab in Three Pediatric Patients with Alopecia Areata Pediatric dermatology · 2018
    19. JAK Inhibitors for Treatment of Alopecia Areata ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 2018
    20. Alopecia Areata After Dupilumab for Atopic Dermatitis JAAD case reports · 2018
    21. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases ˜The œjournal of investigative dermatology. Symposium proceedings/˜The œJournal of investigative dermatology symposium proceedings · 2017
    22. Alopecia Areata: Current Status and Perspectives Archivos Argentinos de Pediatria · 2017
    23. Lack of Efficacy of Apremilast in 9 Patients with Severe Alopecia Areata Journal of the American Academy of Dermatology · 2017
    24. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017
    25. Topical Ruxolitinib for the Treatment of Alopecia Universalis JAMA dermatology · 2015
    26. Extensive Alopecia Areata Is Reversed by IL-12/IL-23p40 Cytokine Antagonism The Journal of Allergy and Clinical Immunology · 2015
    27. The PDE4 Inhibitor, Apremilast, Suppresses Experimentally Induced Alopecia Areata in Human Skin In Vivo Journal of Dermatological Science · 2014
    28. The Pathogenesis of Primary Cicatricial Alopecias The American Journal of Pathology · 2010
    29. Alefacept for Severe Alopecia Areata: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trial Archives of dermatology · 2009